DK1667975T3 - En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin - Google Patents
En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolinInfo
- Publication number
- DK1667975T3 DK1667975T3 DK04765655T DK04765655T DK1667975T3 DK 1667975 T3 DK1667975 T3 DK 1667975T3 DK 04765655 T DK04765655 T DK 04765655T DK 04765655 T DK04765655 T DK 04765655T DK 1667975 T3 DK1667975 T3 DK 1667975T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylsulfonyl
- piperazin
- quinoline
- polymorphic form
- polymorphic
- Prior art date
Links
- JJZFWROHYSMCMU-UHFFFAOYSA-N 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline Chemical compound C=1N=C2C(N3CCNCC3)=CC=CC2=CC=1S(=O)(=O)C1=CC=CC=C1 JJZFWROHYSMCMU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1667975T3 true DK1667975T3 (da) | 2008-04-14 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04765655T DK1667975T3 (da) | 2003-09-26 | 2004-09-23 | En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (da) |
| EP (1) | EP1667975B1 (da) |
| JP (1) | JP2007506702A (da) |
| CN (1) | CN1856471A (da) |
| AU (1) | AU2004283805A1 (da) |
| BR (1) | BRPI0414678A (da) |
| CA (1) | CA2540022A1 (da) |
| CO (1) | CO5680402A2 (da) |
| DE (1) | DE602004010410T2 (da) |
| DK (1) | DK1667975T3 (da) |
| ES (1) | ES2297465T3 (da) |
| GB (1) | GB0322629D0 (da) |
| HR (1) | HRP20080055T3 (da) |
| IL (1) | IL174213A0 (da) |
| IS (1) | IS8399A (da) |
| MA (1) | MA28093A1 (da) |
| MX (1) | MXPA06003375A (da) |
| NO (1) | NO20061791L (da) |
| PL (1) | PL1667975T3 (da) |
| PT (1) | PT1667975E (da) |
| RU (1) | RU2355681C2 (da) |
| WO (1) | WO2005040124A1 (da) |
| ZA (1) | ZA200601453B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE398108T1 (de) * | 2002-03-27 | 2008-07-15 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| EP1558582B1 (en) | 2003-07-22 | 2005-12-21 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| BRPI0410979A (pt) | 2003-09-18 | 2006-07-04 | Axys Pharm Inc | composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia |
| BRPI0611516A2 (pt) | 2005-06-02 | 2010-09-14 | Hoffmann La Roche | 3-metanossulfonilquinolinas como realçadores ("enhancers") de gaba-b |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| US20100041672A1 (en) * | 2007-03-21 | 2010-02-18 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| EP2508177A1 (en) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CN109562085A (zh) | 2015-06-12 | 2019-04-02 | 阿速万科学有限责任公司 | 用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物 |
| HK1247555A1 (zh) | 2015-07-15 | 2018-09-28 | Axovant Sciences Gmbh | 用於預防和治療與神經變性疾病相關的幻覺的作為5-ht2a血清素受體的調節劑的二芳基脲和芳基雜芳基脲衍生物 |
| CN108290842B (zh) * | 2016-05-27 | 2021-04-06 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| ATE398108T1 (de) * | 2002-03-27 | 2008-07-15 | Glaxo Group Ltd | Chinolinderivate und deren verwendung als 5-ht6 liganden |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 HR HR20080055T patent/HRP20080055T3/xx unknown
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en not_active Expired - Lifetime
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en active IP Right Grant
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es not_active Expired - Lifetime
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1856471A (zh) | 2006-11-01 |
| MA28093A1 (fr) | 2006-08-01 |
| IS8399A (is) | 2006-04-05 |
| EP1667975A1 (en) | 2006-06-14 |
| AU2004283805A1 (en) | 2005-05-06 |
| HK1094190A1 (en) | 2007-03-23 |
| HRP20080055T3 (en) | 2008-02-29 |
| IL174213A0 (en) | 2006-08-01 |
| WO2005040124A1 (en) | 2005-05-06 |
| JP2007506702A (ja) | 2007-03-22 |
| ZA200601453B (en) | 2007-04-25 |
| PL1667975T3 (pl) | 2008-04-30 |
| RU2006114024A (ru) | 2007-11-10 |
| NO20061791L (no) | 2006-04-24 |
| RU2355681C2 (ru) | 2009-05-20 |
| BRPI0414678A (pt) | 2006-11-28 |
| ES2297465T3 (es) | 2008-05-01 |
| EP1667975B1 (en) | 2007-11-28 |
| GB0322629D0 (en) | 2003-10-29 |
| CA2540022A1 (en) | 2005-05-06 |
| US20070032504A1 (en) | 2007-02-08 |
| CO5680402A2 (es) | 2006-09-29 |
| DE602004010410D1 (en) | 2008-01-10 |
| DE602004010410T2 (de) | 2008-10-16 |
| MXPA06003375A (es) | 2006-06-08 |
| PT1667975E (pt) | 2008-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0302305D0 (sv) | Novel Compounds | |
| IS8108A (is) | Ný efnasambönd | |
| DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
| IS8228A (is) | Ný asetídínefnasambönd | |
| IS8283A (is) | Umbrotsefni kvetíapíns | |
| IL174213A0 (en) | A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline | |
| IS8292A (is) | Ný efnasambönd | |
| ITMI20042238A1 (it) | Composti per fluoropolirterei | |
| IS8089A (is) | Efnasambönd | |
| NO20031736D0 (no) | Forbindelser | |
| NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
| SE0303452D0 (sv) | New compounds | |
| ITMI20032550A1 (it) | Mescole elastomeriche a base di nerofumo | |
| NO20054532D0 (no) | Fremgangsmater for a forhindre glukonoylering av proteiner | |
| SE0402103D0 (sv) | Novel compounds | |
| SI1667975T1 (sl) | Polimorfna oblika 3-fenilsulfonil-8-piperazin-1-il-kinolina | |
| SE0302667D0 (sv) | Novel Compounds | |
| SE0300388D0 (sv) | Novel compounds | |
| SE0300118D0 (sv) | Novel Compounds | |
| SE0302368D0 (sv) | New compounds | |
| SE0302369D0 (sv) | New compounds | |
| SE0303493D0 (sv) | New compounds | |
| SE0303078D0 (sv) | New compounds | |
| SE0301305D0 (sv) | New compounds | |
| SE0303182D0 (sv) | New compounds |